Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Cord Blood America Remembers World’s First Life Saved by Umbilical Cord Blood Stem Cells

October 7, 2010

LAS VEGAS, Oct. 7 /PRNewswire/ — In celebration of International Stem Cell Awareness Day, Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, has produced an interview with Natalie Curry, whose life was saved by umbilical cord blood stem cells, and her mother, Lea Ann Stiller, who played a key role in this medical breakthrough.

Ms. Curry was diagnosed at age one with Fanconi’s Anemia, a fatal blood disorder. Her only hope was a bone marrow transplant and in St. Louis Hospital in Paris, France, in 1989, stem cells from Natalie’s sister’s umbilical cord blood were used in the successful, first-time procedure.

The interview is available at: http://gaskinsco.com/cbai-10-6-10.mp3 .

Today Natalie serves as official spokesperson for Cord Blood America and the nation’s number one advocate for saving cord blood stem cells at birth. She maintains a blog at http://www.nataliecurry.com/ and her web site at www.allaboutcordblood.com assists in the educational process, including educating nurses and insurance case managers.

“People really don’t understand what they are throwing away; what they can never get back,” Mrs. Stiller said in the interview. She serves as Business Development Director for Cord Blood America.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.


    CONTACT:
    Paul Knopick
    E & E Communications
    949/707-5365
    pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc.


Source: newswire